Patient-Centric Approaches in Retinal Vein Occlusion Treatment | Improving Quality of Life

The Global Retinal Vein Occlusion Treatment Market Size is anticipated to be worth US$ 2.3 billion in 2023, with a CAGR of 5.9% from 2023 to 2033, reaching US$ 4.7 billion. Retinal vein occlusion, which affects those over the age of 65, is one of the most common retinal vascular diseases in the elderly. With age, the chance of retinal vein obstruction increases. The prevalence of retinal vein obstruction is projected to rise as the geriatric population develops.

North America had a high percentage of the global retinal vein occlusion market in 2022 due to various enhanced medical facilities, an increase in the prevalence of eye illnesses, technological improvements, and an ageing population. The Asia Pacific retinal vein occlusion market is anticipated to grow at a 6.5% CAGR between 2023 and 2033. Rising ocular illness prevalence, particularly in China, Singapore, Indonesia, and other Southeast Asian nations, as well as rising health expenditures, are expected to drive East and South Asian market expansion from 2023 to 2033. Throughout the forecast years, Europe is expected to have the second-largest market share. The retinal vein occlusion market in the region is being spurred forward by an ageing population and increased healthcare spending.

The branch retinal vein occlusion sector grew the most in terms of worldwide retinal vein occlusion drug revenue in 2022. As the prevalence of high blood pressure, cardiovascular disease, and glaucoma rises, this sector is likely to dominate the market.

Market Competition

Key players in the Retinal Vein Occlusion Treatment market are AbbVie, Roche, Regeneron Pharmaceuticals, Taiwan Liposome Company, Aerie Pharmaceuticals, Graybug Vision, Kodiak Sciences Inc., Chugai Pharmaceuticals, and Novartis AG among others.

Get More Details@ https://www.futuremarketinsights.com/reports/retinal-vein-occlusion-treatment-market

Key Segments Profiled in the Retinal Vein Occlusion Treatment Industry Survey

By Drug Class:

  • Ranibizumab
  • Dexamethasone
  • Aflibercept
  • Bevacizumab

By Type:

  • Central Retinal Vein Occlusion
  • Branch Retinal Vein Occlusion

By Diagnosis:

  • Optical Coherence Tomography
  • Fundoscopic Examination
  • Fluorescein Angiography

By End User:

  • Hospitals
  • Research and Academics
  • Specialty Clinics

Comments

Post a Comment

Popular posts from this blog

Handheld Ultrasound Scanners Market Will Generate Booming Growth Opportunities to 2032

Image
According to industry predictions, the global Handheld Ultrasound Scanners Market Demand will increase at a CAGR of 9.1% from 2022 to 2032, reaching a value of US$ 472.1 million by the end of 2022. By 2032, sales are estimated to exceed a valuation of roughly US$ 1.1 billion. With an expected 83.6% market share in 2021, the wired modality now leads the sector. Because they connect to Bluetooth or Wi-Fi devices such as mobile phones or tablets, Handheld Ultrasound Scanners are gaining appeal among both medical professionals and non-radiologists. These devices improve networking systems and ease picture transfer to medical facilities. Global Handheld Ultrasound Scanners Market: Dynamics         Technological advancements in medical imaging devices, increased use of Handheld Ultrasound Scanners among non-radiologists, benefits from international trade agreements, increased importing of imaging diagnostics systems, increased use of Handheld Ultrasoun...
Read more

Global Medical face shield Market Insights and Outlook 2022-2032

Image
Medical face shield can become as ubiquitous as masks, as new findings on the airborne spread of Covid-19 influence behavior and guidelines. According to a latest study by Future Market Insights,  Medical Face Shields Market  will grow at over 11% CAGR through 2030. Medical face shields have proven to be an effective first-line defence against airborne diseases such as Zika, SARS, Ebola, flu, and now Covid-19. As a result, increased adoption of medical face shields, and thus increased production, is expected to drive the market during the forecast period. The IDSA (Infectious Diseases Society of America) has included the use of PPE (Personal Protective Equipment) such as face shields and masks in its recommendations. Though masks have been widely used throughout the world, their effectiveness is not widely known. The possibility of cloth masks providing marginal virus protection due to potential moisture retention, poor filtration, and re-use cannot be ruled out. Face ...
Read more

Aesthetic Medical Devices Market 2022-2032: Advanced R&D Process Strategies

Image
A recently published study by FMI expects the global  Aesthetic Medical Devices Market  to augment at a 9.6% CAGR from 2022 to 2032. By the end of the said assessment period, a valuation of US$ 35000 Million is expected for the market. The increase may be attributed mostly to the increased development of technologically advanced and user-friendly devices, as well as the rising desire for cosmetic treatments among individuals. In addition to that, the popularity of minimally invasive and non-invasive aesthetic operations is expanding internationally as a result of loose facial skin, particularly around the eyes, jowls, and cheeks; and dry or roughened skin, among other important changes that occur as a person ages. Furthermore, the demand for aesthetic devices is rising due to the growing popularity of cosmetic operations among those seeking to improve their looks and stand out from the crowd. Key Takeaways from the Market Study FMI projects the global aesthetic ...
Read more